Description
In JetBrains TeamCity before 2023.11.4 path traversal allowing to perform limited admin actions was possible
Published: 2024-03-04
Score: 7.3 High
EPSS: 92.0% High
KEV: Yes
Impact: n/a
Action: n/a
AI Analysis

No analysis available yet.

Remediation

No remediation available yet.

Tracking

Sign in to view the affected projects.

Advisories

No advisories yet.

History

Mon, 20 Apr 2026 20:15:00 +0000

Type Values Removed Values Added
References
Metrics ssvc

{'options': {'Automatable': 'yes', 'Exploitation': 'poc', 'Technical Impact': 'partial'}, 'version': '2.0.3'}

ssvc

{'options': {'Automatable': 'yes', 'Exploitation': 'active', 'Technical Impact': 'partial'}, 'version': '2.0.3'}


Mon, 20 Apr 2026 19:30:00 +0000

Type Values Removed Values Added
Metrics kev

{'dateAdded': '2026-04-20T00:00:00+00:00', 'dueDate': '2026-05-04T00:00:00+00:00'}


Fri, 30 May 2025 17:15:00 +0000

Type Values Removed Values Added
References
Metrics ssvc

{'options': {'Automatable': 'yes', 'Exploitation': 'none', 'Technical Impact': 'partial'}, 'version': '2.0.3'}

ssvc

{'options': {'Automatable': 'yes', 'Exploitation': 'poc', 'Technical Impact': 'partial'}, 'version': '2.0.3'}


Thu, 13 Feb 2025 18:15:00 +0000

Type Values Removed Values Added
Metrics ssvc

{'options': {'Automatable': 'yes', 'Exploitation': 'none', 'Technical Impact': 'partial'}, 'version': '2.0.3'}


Mon, 16 Dec 2024 15:15:00 +0000

Type Values Removed Values Added
First Time appeared Jetbrains
Jetbrains teamcity
Weaknesses CWE-22
CPEs cpe:2.3:a:jetbrains:teamcity:*:*:*:*:*:*:*:*
Vendors & Products Jetbrains
Jetbrains teamcity

Subscriptions

Jetbrains Teamcity
cve-icon MITRE

Status: PUBLISHED

Assigner: JetBrains

Published:

Updated: 2026-04-21T03:55:31.232Z

Reserved: 2024-02-21T09:53:25.423Z

Link: CVE-2024-27199

cve-icon Vulnrichment

Updated: 2024-08-02T00:27:59.868Z

cve-icon NVD

Status : Analyzed

Published: 2024-03-04T18:15:09.377

Modified: 2026-04-21T12:48:17.757

Link: CVE-2024-27199

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses